IDX
Integral Diagnostics Limited
1 day chart
About IDX
Integral Diagnostics Limited (IDX) is an Australian healthcare services company whose main activity is providing Diagnostic Imaging Services to general practitioners, medical specialists and allied health professionals (Referrers) and their patients.
Buy Australian shares starting with IDX. Invest today with a CHESS-sponsored investing platform!
Market Capitalisation
$670M
Price-earnings ratio
26.98
Dividend yield
1.99%
High today
$2.89
Low today
$2.84
Open price
$2.89
52-week high
$3.54
52-week low
$2.40
Announcements
IDX FAQs
Can I buy IDX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake platform allows you to buy IDX shares and over 8,000 stocks and ETFs across the ASX and Wall St.
How much is one share of Integral Diagnostics Limited?
One share of Integral Diagnostics Limited is valued at $2.87.
What is the ticker symbol for Integral Diagnostics Limited?
The ticker symbol for Integral Diagnostics Limited is IDX.
How do I buy IDX shares in Australia?
To buy IDX stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in IDX
What is the 52-week high for Integral Diagnostics Limited stock?
The Integral Diagnostics Limited 52-week high stock price is $3.54.
What is the 52-week low for Integral Diagnostics Limited stock?
The Integral Diagnostics Limited 52-week low stock price is $2.40.
What is the market capitalisation of Integral Diagnostics Limited IDX?
As of 26/09/2023 Integral Diagnostics Limited has a market cap of $670M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.